SEC Form D private-offering filing

Dualitas Therapeutics, Inc.

Name: Dualitas Therapeutics, Inc. - new SEC Form D private-offering filing, South San Francisco, CA
Published: 2025-11-18

A new SEC Form D private-offering notice from South San Francisco, CA, a $66,599,990 filer-stated offering target in Biotech. The source filing is one click away.

Dualitas Therapeutics, Inc. site↗ Verified via SEC Form D

Develops bispecific antibody medicines for immune and inflammatory disease using its DualScreen discovery engine.

Filed 2025-11-18Filed to raise $66,599,990First money in 2025-07-07Raised so far $32,599,997HQ (as filed) South San Francisco, CASector Biotech ✓Stage (inferred) GrowthCall status Late filing

Source linked the Form D on EDGAR↗Website verified dualitastx.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.